Cancer immunotherapy using cells modified with cytokine genes

Area of Science:

• Immunology
• Oncology
• Gene Therapy

Background:

• Cytokines show potential in hampering tumor growth and inducing anti-tumor immune responses.
• Cytokine-based gene therapy is being investigated as a novel cancer treatment approach.

Purpose of the Study:

• To review strategies for costimulating anti-tumor immune responses using cytokine gene modification of various cell types.
• To discuss the promises and limitations of cytokine-based cancer gene therapy.

Main Methods:

• Review of ex vivo modification of tumor cells (whole tumor cell vaccines) and other cell types for cytokine gene delivery.
• Review of in vivo delivery of cytokine genes into the tumor microenvironment and ex vivo modification of dendritic cells.
• Discussion of the application of single and multiple cytokine genes, often combined with chemokines, co-stimulatory molecules, or tumor-associated antigens.

Main Results:

• Multiple strategies for cytokine gene therapy have emerged, including ex vivo and in vivo approaches.
• Combinations of cytokine genes with other therapeutic factors enhance anti-tumor immune responses.
• Clinical trials are evaluating the efficacy of these cytokine-based gene therapy strategies.

Conclusions:

• Cytokine gene therapy offers promising avenues for cancer treatment by enhancing anti-tumor immunity.
• Various strategies exist for modifying cells with cytokine genes to stimulate immune responses.
• Further research and clinical trials are necessary to fully realize the potential and overcome limitations of cytokine-based cancer gene therapy.